These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19150476)

  • 1. A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design.
    Chen HW; Liu SJ; Liu HH; Kwok Y; Lin CL; Lin LH; Chen MY; Tsai JP; Chang LS; Chiu FF; Lai LW; Lian WC; Yang CY; Hsieh SY; Chong P; Leng CH
    Vaccine; 2009 Feb; 27(9):1400-9. PubMed ID: 19150476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical characterizations of Escherichia coli-expressed protective antigen Ag473 of Neisseria meningitides group B.
    Sung JW; Hsieh SY; Lin CL; Leng CH; Liu SJ; Chou AH; Lai LW; Lin LH; Kwok Y; Yang CY; Chong P
    Vaccine; 2010 Nov; 28(51):8175-82. PubMed ID: 20937316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying biotin-streptavidin binding for iscom (immunostimulating complex) association of recombinant immunogens.
    Wikman M; Friedman M; Pinitkiatisakul S; Hemphill A; Lövgren-Bengtsson K; Lundén A; Ståhl S
    Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):163-74. PubMed ID: 15296488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoproteomic identification of the hypothetical protein NMB1468 as a novel lipoprotein ubiquitous in Neisseria meningitidis with vaccine potential.
    Hsu CA; Lin WR; Li JC; Liu YL; Tseng YT; Chang CM; Lee YS; Yang CY
    Proteomics; 2008 May; 8(10):2115-25. PubMed ID: 18491322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins.
    Lei B; Liu M; Chesney GL; Musser JM
    J Infect Dis; 2004 Jan; 189(1):79-89. PubMed ID: 14702157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hybrid outer membrane protein antigen for vaccination against Pseudomonas aeruginosa.
    Gabelsberger J; Knapp B; Bauersachs S; Enz UI; von Specht BU; Domdey H
    Behring Inst Mitt; 1997 Feb; (98):302-14. PubMed ID: 9382754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of medium components on the expression of recombinant lipoproteins in Escherichia coli.
    Tseng CL; Leng CH
    Appl Microbiol Biotechnol; 2012 Feb; 93(4):1539-52. PubMed ID: 21822641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of lipidated meningococcal transferrin binding protein 2 in Escherichia coli.
    Legrain M; Speck D; Jacobs E
    Protein Expr Purif; 1995 Oct; 6(5):570-8. PubMed ID: 8535148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new cloning system based on the OprI lipoprotein for the production of recombinant bacterial cell wall-derived immunogenic formulations.
    Basto AP; Piedade J; Ramalho R; Alves S; Soares H; Cornelis P; Martins C; Leitão A
    J Biotechnol; 2012 Jan; 157(1):50-63. PubMed ID: 22115954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial lipid modification of proteins for novel protein engineering applications.
    Kamalakkannan S; Murugan V; Jagannadham MV; Nagaraj R; Sankaran K
    Protein Eng Des Sel; 2004 Oct; 17(10):721-9. PubMed ID: 15556968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification and immunodetection of a recombinant fragment (residues 179-281) of the G protein from rabies virus ERA strain.
    Bassi EJ; Vernal J; Zanluca C; Terenzi H; Zanetti CR
    Protein Expr Purif; 2008 Jun; 59(2):309-13. PubMed ID: 18406167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant bacterial lipoproteins as vaccine candidates.
    Leng CH; Liu SJ; Chen HW; Chong P
    Expert Rev Vaccines; 2015; 14(12):1623-32. PubMed ID: 26420467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General strategies for efficient adjuvant incorporation of recombinant subunit immunogens.
    Wikman M; Friedman M; Pinitkiatisakul S; Andersson C; Hemphill A; Lövgren-Bengtsson K; Lundén A; Ståhl S
    Vaccine; 2005 Mar; 23(17-18):2331-5. PubMed ID: 15755622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel cytochrome c peroxidase from Neisseria gonorrhoeae: a lipoprotein from a Gram-negative bacterium.
    Turner S; Reid E; Smith H; Cole J
    Biochem J; 2003 Aug; 373(Pt 3):865-73. PubMed ID: 12720546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant Lipoproteins as Novel Vaccines with Intrinsic Adjuvant.
    Chong P; Huang JH; Leng CH; Liu SJ; Chen HW
    Adv Protein Chem Struct Biol; 2015; 99():55-74. PubMed ID: 26067816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
    Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J
    Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunomodulatory activity of meningococcal lipoprotein Ag473 depends on the conformation made up of the lipid and protein moieties.
    Chu CL; Yu YL; Kung YC; Liao PY; Liu KJ; Tseng YT; Lin YC; Hsieh SS; Chong PC; Yang CY
    PLoS One; 2012; 7(7):e40873. PubMed ID: 22844415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo and in vitro lipidation of recombinant immunogens for direct iscom incorporation.
    Andersson C; Wikman M; Lövgren-Bengtsson K; Lundén A; Ståhl S
    J Immunol Methods; 2001 Sep; 255(1-2):135-48. PubMed ID: 11470294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Production of recombinant fragments of the Clostridium tetani neurotoxin for the development of new immune-prophylaxis preparations against tetanus].
    Varfolomeeva NA; Makhotina OA; Sergeeva TI; Belyĭ IuF
    Mol Gen Mikrobiol Virusol; 2003; (3):29-33. PubMed ID: 12966924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.